Literature DB >> 19104142

CD4+ T cells mediate cytotoxicity in neurodegenerative diseases.

Stanley H Appel1.   

Abstract

Neuroinflammation, characterized by activated microglia and infiltrating T cells, is a prominent pathological feature in neurodegenerative diseases. However, whether this inflammation contributes to neuronal injury or is a late consequence of neuronal injury is unclear. In this issue of the JCI, Brochard et al. report that CD4+ T cells are cytotoxic in a mouse model of Parkinson disease (PD) (see the related article beginning on page 182). Specifically, invading T lymphocytes contributed to neuronal cell death via the Fas/FasL pathway. The results implicate the adaptive immune system in the pathogenesis of Parkinson neurodegeneration and provide a meaningful rationale for immune-based therapies for PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19104142      PMCID: PMC2613473          DOI: 10.1172/JCI38096

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

Review 1.  The chemokine system in diverse forms of macrophage activation and polarization.

Authors:  Alberto Mantovani; Antonio Sica; Silvano Sozzani; Paola Allavena; Annunciata Vecchi; Massimo Locati
Journal:  Trends Immunol       Date:  2004-12       Impact factor: 16.687

2.  The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS.

Authors:  Jenny S Henkel; David R Beers; László Siklós; Stanley H Appel
Journal:  Mol Cell Neurosci       Date:  2005-12-05       Impact factor: 4.314

3.  Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

Authors:  D C Wu; Vernice Jackson-Lewis; Miquel Vila; Kim Tieu; Peter Teismann; Caryn Vadseth; Dong-Kug Choi; Harry Ischiropoulos; Serge Przedborski
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

4.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.

Authors:  Matthew P Mount; Arman Lira; David Grimes; Patrice D Smith; Sylvie Faucher; Ruth Slack; Hymie Anisman; Shawn Hayley; David S Park
Journal:  J Neurosci       Date:  2007-03-21       Impact factor: 6.167

6.  Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages.

Authors:  David R Park; Anni R Thomsen; Charles W Frevert; Uyenvy Pham; Shawn J Skerrett; Peter A Kiener; W Conrad Liles
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

7.  Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.

Authors:  J W Langston; L S Forno; J Tetrud; A G Reeves; J A Kaplan; D Karluk
Journal:  Ann Neurol       Date:  1999-10       Impact factor: 10.422

8.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.

Authors:  Hania Kebir; Katharina Kreymborg; Igal Ifergan; Aurore Dodelet-Devillers; Romain Cayrol; Monique Bernard; Fabrizio Giuliani; Nathalie Arbour; Burkhard Becher; Alexandre Prat
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

9.  Rate of cell death in parkinsonism indicates active neuropathological process.

Authors:  P L McGeer; S Itagaki; H Akiyama; E G McGeer
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

10.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

View more
  34 in total

1.  Inflammation in neuroviral diseases.

Authors:  Pascale Giraudon; Arlette Bernard
Journal:  J Neural Transm (Vienna)       Date:  2010-08       Impact factor: 3.575

Review 2.  Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.

Authors:  Oliver Cooper; Arnar Astradsson; Penny Hallett; Harold Robertson; Ivar Mendez; Ole Isacson
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

3.  In search of an immunobiomarker for Parkinson's disease.

Authors:  Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-09       Impact factor: 4.147

4.  Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats.

Authors:  Harikesh Kalonia; Jitendriya Mishra; Anil Kumar
Journal:  Neurotox Res       Date:  2012-03-06       Impact factor: 3.911

5.  Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.

Authors:  Giulia Ambrosi; Natasa Kustrimovic; Francesca Siani; Emanuela Rasini; Silvia Cerri; Cristina Ghezzi; Giuseppe Dicorato; Sofia Caputo; Franca Marino; Marco Cosentino; Fabio Blandini
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

6.  Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts.

Authors:  James E Balow; John G Ryan; Jae Jin Chae; Matthew G Booty; Ariel Bulua; Deborah Stone; Hong-Wei Sun; James Greene; Beverly Barham; Raphaela Goldbach-Mansky; Daniel L Kastner; Ivona Aksentijevich
Journal:  Ann Rheum Dis       Date:  2012-12-05       Impact factor: 19.103

Review 7.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

Review 8.  CD 4+ T cells in the pathobiology of neurodegenerative disorders.

Authors:  Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-05-12       Impact factor: 3.478

9.  PR-957 mediates neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke.

Authors:  Y Guo; X Chen; D Li; H Liu; Y Ding; R Han; Y Shi; X Ma
Journal:  Clin Exp Immunol       Date:  2018-04-23       Impact factor: 4.330

10.  Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders.

Authors:  R Lee Mosley; Howard E Gendelman
Journal:  Exp Neurol       Date:  2010-01-04       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.